COMMUNIQUÉS West-GlobeNewswire

Reviewed Financial Statement's announcement for the period 30 June 2018
13/08/2018
EASTPHARMA LTD. London, 13 August 2018 - EastPharma (EAST LI) announces that it is releasing its reviewed financial statements for the period 30 June 2018 and a review of its main subsidiary DEVA Holding's financial [...]
XBiotech présente une mise à jour trimestrielle de ses activités
13/08/2018
L'entreprise fournit une vue d'ensemble sur sa position financière et ses avancées dans les domaines clinique et de la recherche AUSTIN, Texas, 13 août 2018 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) a fourni une [...]
Allscripts open ecosystem drives healthcare data interoperability
13/08/2018
Global health IT leader enables more than four billion API data shares since 2013; applauds Microsoft and others’ joint commitment to help move healthcare towards the cloud CHICAGO, Aug. 13, 2018 (GLOBE NEWSWIRE) -- [...]
The Cooper Companies to Participate in the Baird Global Healthcare Conference
13/08/2018
PLEASANTON, Calif., Aug. 13, 2018 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE: COO) will participate in the Baird 2018 Global Healthcare Conference in New York, NY, on September 5, 2018. Albert G. White III, [...]
Mustang Bio Reports Second Quarter 2018 Financial Results and Recent Corporate Highlights
13/08/2018
NEW YORK, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a Fortress Biotech (NASDAQ: FBIO) Company focused on the development of novel immunotherapies based on proprietary chimeric [...]
ImmuCell Announces Financial Results for Second Quarter of 2018
13/08/2018
PORTLAND, Maine, Aug. 13, 2018 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically-proven and [...]
Unum Therapeutics Announces Active Investigational New Drug (IND) Application for Antibody-Coupled T Cell Receptor (ACTR) platform in Combination with Trastuzumab in Patients with HER2+ Advanced Cancers
13/08/2018
– First Solid Tumor Product Candidate Based on Unum’s universal ACTR Technology – – Phase 1 Study Expected to Initiate by the End of 2018 – CAMBRIDGE, Mass., Aug. 13, 2018 (GLOBE NEWSWIRE) -- Unum Therapeutics Inc. ( [...]
Cesca Therapeutics Announces Second Quarter 2018 Financial Results and Provides Corporate Update
13/08/2018
Conference Call to be Held at 4:30 p.m. ET (1:30 p.m. PT) RANCHO CORDOVA, Calif., Aug. 13, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, [...]
Unum Therapeutics Reports Second Quarter 2018 Financial Results and Provides Business Update
13/08/2018
– IND for First Solid Tumor Program, ACTR T cells in Combination with Trastuzumab in Patients with HER2+ Advanced Cancers Now Active; Expect to Initiate Phase I Trial by End of 2018 – CAMBRIDGE, Mass., Aug. 13, 2018 ( [...]
electroCore, Inc. Announces Second Quarter Financial Results
13/08/2018
BASKING RIDGE, N.J., Aug. 13, 2018 (GLOBE NEWSWIRE) -- electroCore, Inc. (“electroCore”) (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today reported financial results for the three month and six [...]
Acer Therapeutics Reports Second Quarter 2018 Financial Results and Provides Corporate Update
13/08/2018
Acer continues to progress towards goal of commercializing EDSIVO™ Company appoints VPs of Medical Affairs and Quality NEWTON, Mass., Aug. 13, 2018 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a [...]
Forty Seven Inc. Reports Second Quarter 2018 Financial Results and Recent Business Highlights
13/08/2018
-- Presented Preliminary Data from Three Clinical Trials of 5F9 as a Monotherapy and Combination Agent -- -- Granted Fast Track Designation from the U.S. Food and Drug Administration for 5F9 in Diffuse Large B-Cell [...]
Achaogen to Present at the Wedbush PacGrow Healthcare Conference
13/08/2018
-- Company presentation scheduled for August 14, 2018 at 8:00 a.m. EDT -- SOUTH SAN FRANCISCO, Calif., Aug. 13, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ: AKAO), a biopharmaceutical company discovering, developing [...]
Gemphire Therapeutics Reports Second Quarter 2018 Financial Results and Provides Corporate Update
13/08/2018
LIVONIA, Mich., Aug. 13, 2018 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ: GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders, [...]
Avinger Announces Second Quarter 2018 Financial Results
13/08/2018
REDWOOD CITY, Calif., Aug. 13, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today reported results for the second quarter ended [...]
Tetra Bio-Pharma Announces Initiation of Coverage by Paradigm Capital
13/08/2018
ORLEANS, Ontario, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc ., a leader in cannabinoid-based drug discovery and development (TSX VENTURE:TBP) (OTCQB:TBPMF), today announced that Paradigm Capital, an [...]
Certis Oncology Partners With Reveal Biosciences to Offer Advanced Pre-Clinical Oncology Services
13/08/2018
SAN DIEGO, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Certis Oncology Solutions and Reveal Biosciences today announced a strategic partnership in which the two companies will collaborate to provide an innovative, next-generation [...]
Park Vista Health Center Named Great Place to Work
13/08/2018
FULLERTON, Calif., Aug. 13, 2018 (GLOBE NEWSWIRE) -- Park Vista Health Center in Fullerton, California, has been certified as a top workplace by the independent research and consulting firm Great Place to Work ®. Great [...]
CMS Proposed Rule Aims at AMA-Designed Paperwork Burden, States the Association of American Physicians and Surgeons (AAPS)
13/08/2018
TUCSON, Ariz., Aug. 13, 2018 (GLOBE NEWSWIRE) -- The Centers for Medicare and Medicaid Services (CMS) has issued a Proposed Rule to “blend” payments for higher-level office visits, while decreasing the documentation [...]

Pages